China Pharma Holdings, Inc.
CPHINYSECIK 1106644HealthcareFiscal year ends Dec 31
Reports and events: 162 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2021-11-2316:30 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001213900-21-061610 |
| 2021-11-1517:12 ET | DEF 14A | Proxy statementPeriod 2021-12-27 | 0001213900-21-059533 |
| 2021-11-1216:06 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001213900-21-058670 |
| 2021-09-1516:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-21-048212 |
| 2021-08-1316:06 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001213900-21-042474 |
| 2021-05-1416:09 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001213900-21-026413 |
| 2021-03-2616:05 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001213900-21-017981 |
| 2020-12-2916:09 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001213900-20-045181 |
| 2020-11-1616:06 ET | DEF 14A | Proxy statementPeriod 2020-12-28 | 0001213900-20-037345 |
| 2020-11-1316:05 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001213900-20-036919 |
| 2020-08-1316:08 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001213900-20-021867 |
| 2020-05-1416:07 ET | 10-Q | Quarterly reportPeriod 2020-03-31 | 0001213900-20-012258 |
| 2020-03-3016:45 ET | 10-K | Annual reportPeriod 2019-12-31 | 0001213900-20-008020 |
| 2019-12-2316:04 ET | 8-K | 5.07 Shareholder vote results | 0001213900-19-026825 |
| 2019-11-1416:05 ET | 10-Q | Quarterly reportPeriod 2019-09-30 | 0001213900-19-023467 |
| 2019-11-0617:26 ET | DEF 14A | Proxy statementPeriod 2019-12-19 | 0001213900-19-022241 |
| 2019-08-1416:06 ET | 10-Q | Quarterly reportPeriod 2019-06-30 | 0001213900-19-015792 |
| 2019-05-1416:13 ET | 10-Q | Quarterly reportPeriod 2019-03-31 | 0001213900-19-008566 |
| 2019-03-2816:04 ET | 10-K | Annual reportPeriod 2018-12-31 | 0001213900-19-005094 |
| 2018-12-0616:06 ET | 8-K | 5.07 Shareholder vote results | 0001213900-18-017006 |
| 2018-11-1416:08 ET | 10-Q | Quarterly reportPeriod 2018-09-30 | 0001213900-18-015783 |
| 2018-10-2514:23 ET | DEF 14A | Proxy statementPeriod 2018-12-05 | 0001213900-18-014459 |
| 2018-08-1416:02 ET | 10-Q | Quarterly reportPeriod 2018-06-30 | 0001213900-18-010992 |
| 2018-05-1416:01 ET | 10-Q | Quarterly reportPeriod 2018-03-31 | 0001213900-18-006100 |
| 2018-04-0216:54 ET | 10-K | Annual reportPeriod 2017-12-31 | 0001213900-18-003895 |
| 2018-03-1216:05 ET | 8-K | 8.01 Other events | 0001213900-18-002824 |
| 2017-12-1816:05 ET | 8-K | 5.07 Shareholder vote results | 0001213900-17-013370 |
| 2017-11-1415:57 ET | 10-Q | Quarterly reportPeriod 2017-09-30 | 0001213900-17-012067 |
| 2017-11-0317:01 ET | DEF 14A | Proxy statementPeriod 2017-12-14 | 0001213900-17-011352 |
| 2017-09-1216:10 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001213900-17-009599 |
| 2017-08-1416:08 ET | 10-Q | Quarterly reportPeriod 2017-06-30 | 0001213900-17-008653 |
| 2017-05-1117:02 ET | 10-Q | Quarterly reportPeriod 2017-03-31 | 0001010549-17-000167 |
| 2017-03-3116:21 ET | 10-K | Annual reportPeriod 2016-12-31 | 0001010549-17-000112 |
| 2017-03-3106:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-17-003047 |
| 2016-12-2816:05 ET | 8-K | 8.01 Other events | 0001010549-16-000877 |
| 2016-12-1316:07 ET | 8-K | 5.07 Shareholder vote results | 0001010549-16-000864 |
| 2016-12-0216:10 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001010549-16-000834 |
| 2016-11-1416:07 ET | 10-Q | Quarterly reportPeriod 2016-09-30 | 0001010549-16-000787 |
| 2016-10-2815:52 ET | DEF 14A | Proxy statementPeriod 2016-12-08 | 0001010549-16-000755 |
| 2016-08-1116:25 ET | 10-Q | Quarterly reportPeriod 2016-06-30 | 0001010549-16-000678 |
| 2016-05-1616:41 ET | 10-Q | Quarterly reportPeriod 2016-03-31 | 0001010549-16-000606 |
| 2016-03-3016:11 ET | 10-K | Annual reportPeriod 2015-12-31 | 0001010549-16-000541 |
| 2015-12-2807:48 ET | 10-Q/A | Quarterly report, amendedPeriod 2015-09-30 | 0001010549-15-000422 |
| 2015-12-2807:46 ET | 10-Q/A | Quarterly report, amendedPeriod 2015-06-30 | 0001010549-15-000420 |
| 2015-12-2807:43 ET | 10-Q/A | Quarterly report, amendedPeriod 2015-03-31 | 0001010549-15-000418 |
| 2015-12-2807:39 ET | 10-K/A | Annual report, amendedPeriod 2014-12-31 | 0001010549-15-000416 |
| 2015-12-1116:05 ET | 8-K | 4.02 Non-reliance on financial statements; 9.01 Financial statements and exhibits | 0001010549-15-000389 |
| 2015-12-1016:05 ET | 8-K | 5.07 Shareholder vote results | 0001010549-15-000387 |
| 2015-11-1616:10 ET | 10-Q | Quarterly reportPeriod 2015-09-30 | 0001010549-15-000343 |
| 2015-10-2917:36 ET | DEF 14A | Proxy statementPeriod 2015-12-08 | 0001010549-15-000313 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:51 ET. Listed shows no prices and gives no investment advice.